Brasada Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-4,685	Closed	-$717K	–	156
2020 Q4	$717K	Buy	+4,685	New	+$717K	0.16%	101